You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
30 May 2018
Sirion Biotech GmbH: Next-generation AAV gene therapy from joined German forces
8 January 2018
SIRION Biotech and Acucela Set Sights on Gene Delivery Tools for Ocular Gene Therapy
29 September 2017
SIRION Biotech and Vibalogics partner to offer complete Adeno-Associated Virus (AAV) services
12 January 2017
Sirion Biotech GmbH: Breakthrough technology improves genetic stem cell therapies
16 June 2016
New opportunities with advanced viral vector technologies for novel therapies & vaccines
1 February 2016
Sirion Biotech GmbH: Matured vector technologies open industrial genetherapy and vaccine markets to German Biotech
21 December 2015
Sirion Biotech: Breakthrough for preclinical vaccine vectors (news with additional features)
28 October 2015
Progress made with novel breakthrough vaccines: new production cell lines cope with difficult to express toxic antigensirion Biotech GmbH: (news with additional features)
7 August 2015
Progress Published in Screening for New Cancer Compounds in Context of Radiation Therapy
27 April 2015
Viral Vector Technologies from Europe directly accessible in Boston
19 August 2014
Tissue specific optimized AAV Plasmids are now available to make research & therapy more targeted
12 June 2014
Adenovirus Vectors meet critical FDA requirement regarding risk of contamination with infectious agents; a critical hurdle on their way to clinical studies can be overcome
25 March 2014
Overcoming hurdles of HCMV vaccine development: Munich researchers claim progress
20 March 2014
Human Taste Sensation can now be investigated on a molecular level with stably proliferating Human Taste Cells
13 March 2014
SIRION Biotech’s adenovirus platform technology allows for overexpres-sion of BACH2: BACH2 plays role in type 1 Diabetes by regulating pancreatic β-cell apoptosis
17 February 2014
Horizon Discovery Signs Supply and Distribution Agreement with SIRION Biotech
19 December 2013
Sirion Biotech GmbH: Viral vectors made in human expression system allow for safer and more efficient production of novel vaccines and gene therapy
9 April 2013
Sirion Biotech GmbH: Viral vectors for novel cell models, gene therapy and vaccine development gain further funds from private investors
4 December 2012
Sirion Biotech GmbH: Adeno-associated virus now easily available for research and preclinical studies
